FWIW - As of 2021; only 950 of the 5,800 products awarded 'Orphan Drug Designation' status ever made it to approval (i.e. ~16%). All 5 of IMU's platforms could receive ODD and odds are that none make it to approval.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)